Nobel Laureate Keynote
Max-Planck Institut f. Biochemistry, Germany.
Foreign attendees of InCoB 2009 would need a "business visa" (which is also called an "entry pass for social visit") for entry into Singapore.
For citizens of most countries, this can be obtained on-the-spot at the Singapore Changi Airport.
But for citizens of some countries, this visa should be obtained in advance. These countries are: Afghanistan, Algeria, Bangladesh, Commonwealth of Independent
States, Egypt, India, Iran, Iraq, Jordan, Lebanon, Libya, Morocco, Myanmar, People's Republic of China, Pakistan, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, Yemen.
Please do NOT apply for the "professional visit pass", as it is not for speakers and attendees of scientific meetings.
Click here for more VISA and Entry information.
Please contact email@example.com if you need a letter of invitation to apply for the visa.
A modest fellowship fund is available to assist students and post-doctoral trainees in attending InCoB 2009 for the purposes of presenting their paper/poster.
Only one author for a paper/poster will be eligible for a travel grant. Applications for travel awards are hereby invited. All travel grant applications must be received before 28 June 2009. Award decisions will finalized by 11 July 2009, at which time
applicants will be notified by email. The size of each award is expected to be SGD500.
To apply for a travel fellowship, please email the following information to
Legal name (for financial purposes)
Optional: Name and title by which you prefer to be addressed
Status (student, postdoc)
Institution and location of institution (e.g., university address) including country
Preferred mailing address, if different from university address
Brief statement about availability of other funding sources
Poster/Paper submission ID
#Please note that travel grant award is subject to acceptance of paper/poster for presentation at InCoB 2009.
This announcement may be freely redistributed. All the best in your applications and see you at the conference.